Thalamos helps those with acute mental illness access care more quickly.
Business overview
Location | London, United Kingdom |
---|---|
Social media | |
Website | www.thalamos.co.uk |
Sectors | Healthcare Digital B2B |
Company number | 10814088 |
Incorporation date | 12 Jun 2017 |
Pre-emption
Pre-emption details
Thalamos is currently raising around £343k from new and existing investors. This campaign gives Seedrs investors the ability to take up their pre-emption rights in the round. Please note, Seedrs investors are able to invest over their pre-emption allocation if they wish, up to an aggregate maximum amount of £56k.
The share price for this round is £13.387309, equivalent to a fully diluted pre-money valuation of £2,510,000. For the purposes of this campaign, this share price has been rounded to £13.39 so that investors can subscribe for whole shares. This is a slightly lower share price than the last round of £13.45 due to an slight increase in the company's option pool which is now just under 10% of the company's fully diluted share capital.
As this is a pre-emption campaign limited information is provided. More information can be found by reviewing the business's post investment page. This information has not been reviewed or approved by Seedrs.
Open an account to get access to the team members of Thalamos
Already have an account? Log in
To comply with financial regulations, we can only show full campaign details to registered users.
Only shareholders can access this page
If you successfully purchase a share lot of this business, you will be granted access.
Buy sharesOnly shareholders can access this page
If you successfully purchase a share lot of this business, you will be granted access.
Buy sharesOnly shareholders can access this page
If you successfully purchase a share lot of this business, you will be granted access.
Buy sharesOnly shareholders can access this page
If you successfully purchase a share lot of this business, you will be granted access.
Buy shares